Murtazaeva, Z.; Nasrullaev, A.; Buronov, A.; Gaybullaev, S.; Nie, L.; Numonov, S.; Khushnazarov, Z.; Turgunov, D.; Kuryazov, R.; Zhao, J.;
et al. Imidazole Hybrids: A Privileged Class of Heterocycles in Medicinal Chemistry with New Insights into Anticancer Activity. Molecules 2025, 30, 2245.
https://doi.org/10.3390/molecules30102245
AMA Style
Murtazaeva Z, Nasrullaev A, Buronov A, Gaybullaev S, Nie L, Numonov S, Khushnazarov Z, Turgunov D, Kuryazov R, Zhao J,
et al. Imidazole Hybrids: A Privileged Class of Heterocycles in Medicinal Chemistry with New Insights into Anticancer Activity. Molecules. 2025; 30(10):2245.
https://doi.org/10.3390/molecules30102245
Chicago/Turabian Style
Murtazaeva, Zarifa, Azizbek Nasrullaev, Anvarjon Buronov, Shukhrat Gaybullaev, Lifei Nie, Sodik Numonov, Zohidjon Khushnazarov, Davron Turgunov, Rustamkhon Kuryazov, Jiangyu Zhao,
and et al. 2025. "Imidazole Hybrids: A Privileged Class of Heterocycles in Medicinal Chemistry with New Insights into Anticancer Activity" Molecules 30, no. 10: 2245.
https://doi.org/10.3390/molecules30102245
APA Style
Murtazaeva, Z., Nasrullaev, A., Buronov, A., Gaybullaev, S., Nie, L., Numonov, S., Khushnazarov, Z., Turgunov, D., Kuryazov, R., Zhao, J., & Bozorov, K.
(2025). Imidazole Hybrids: A Privileged Class of Heterocycles in Medicinal Chemistry with New Insights into Anticancer Activity. Molecules, 30(10), 2245.
https://doi.org/10.3390/molecules30102245
